Skip to main content

Table 7 Distribution of dystrophin gene mutation types according to secondary endpoint occurrence

From: Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

Dystrophin gene mutation type

Total (N = 81)

Secondary endpoint (N = 18)

No endpoint (N = 63)

p-value

Deletions affecting the amino-terminal domain, n (%)

11 (14)

3 (17)

8 (13)

1.00

Deletions affecting exons 45–49, n (%)

30 (37)

7 (39)

23 (37)

0.79

Deletions affecting exons 50 and/or 51, n (%)

15 (19)

2 (11)

13 (21)

0.75

Duplication, n (%)

11 (14)

5 (28)

6 (10)

0.13

Point mutation, n (%)

4 (5)

1 (5)

3 (5)

1.00

Other, n (%)

10 (12)

0 (0)

10 (16)

0.06

  1. DMD – Duchene muscular dystrophy; BMD – Becker muscular dystrophy.